Feb 13 (Reuters) - Conduit Pharmaceuticals CDT.O:
CONDUIT PHARMACEUTICALS INC: PARTNERS WITH CHARLES RIVER IN CLINICALLY RELEVANT SYSTEMIC LUPUS ERYTHEMATOSUS MODEL
CONDUIT PHARMACEUTICALS: STUDY TO ACCELERATE DEVELOPMENT OF AZD1656 FOR AUTOIMMUNE DISORDERS, FOCUS ON SYSTEMIC LUPUS ERYTHEMATOSUS, LUPUS NEPHRITIS
Source text: ID:nGNX6dgWCT
Further company coverage: CDT.O